News

• Further team expansion at Bind
  06 Oct 2025

  We have welcomed a further four new team members this last month into pivotal roles for Bind.

• Bind moves into its labs at London BioScience Innovation Centre (LBIC)
  02 Oct 2025

  Bind has taken up a lease for 2,746 sq. ft of state-of-the-art lab and office space at the Apex Building, Tribeca. In the words of our CEO, Gabi Heller, “We’re excited to be joining the vibrant LBIC community at the Apex. This space offers the flexibility and infrastructure we need to build a world-class not-for-profit research organisation. For a mission like ours, namely transforming drug discovery for disordered proteins, it’s crucial to be embedded in an environment that fosters collaboration, innovation, and scientific excellence.”

• Additional new team members join Bind
  01 Sep 2025

  Over the last 3 months we are delighted to have welcomed five stellar new members of the team to Bind.

• New Hires at Bind
  06 Jun 2025

  It’s been an exciting week at Bind Research! We’re thrilled to welcome three exceptional people to the team. Dr Acely Garza-Garcia, an expert biochemist formerly at the Francis Crick Institute, joins us as Senior Scientist, Biochemistry and Biophysics. Her expertise will be instrumental in building our dataset and advancing our platform. Dr Candide Champion a talented computational chemist who recently completed his PhD at ETH Zurich, joins us as a Scientific Software Engineer. His deep knowledge of molecular modelling and software development is a fantastic addition to our capabilities. Sam Patterson is a bright undergraduate student at Duke University who is visiting Bind for the summer to learn about proteins, drug discovery, and startups. Welcome, Acely, Candide, and Sam! We’re so glad to have you on board!

• Gratitude for Our Trajectory to Date
  12 Feb 2025

  Earlier this week, we announced the launch of Bind Research, a new not-for-profit organisation dedicated to delivering tools and datasets to make disordered proteins druggable.

• Bind Research launched to transform disordered proteins into effective drug targets
  11 Feb 2025
  London, UK – 11 February 2025 – Bind Research was today launched as the UK’s first not-for-profit Focused Research Organisation (FRO), committed to transforming drug discovery by targeting disordered proteins - an approach that promises new therapeutic avenues for diseases once considered untreatable.
• Bind Research is founded
  09 Jan 2025

  Bind Research has officially incorporated, marking a significant milestone as it embarks on its mission to drive breakthrough advancements targeting intrinsically disordered proteins.

• Bind at the Research Ventures Catalyst Investor Event
  11 Jul 2024

  Bind is pitching at the Investor Event for the Research Ventures Catalyst programme. Find us at the Francis Crick Institute on July 23rd (more information here).

• Marcus Harrison joins Bind Research as COO
  26 Jun 2024

  Bind Research is excited to welcome Dr Marcus Harrison as Chief Operating Officer.

• Melissa Strange joins Bind Research as CFO
  25 Jun 2024

  Bind Research is delighted to welcome Melissa Strange in her new role as Chief Financial Officer.

• Bind is a Research Ventures Catalyst finalist
  11 Jun 2024

  Bind is a finalist in the UK Department for Science, Innovation, and Technology (DSIT) Research Ventures Catalyst programme.

• Bind is pitching for the Research Ventures Catalyst
  18 Jan 2024

  Bind is pitching in the UK Department for Science, Innovation, and Technology (DSIT) Research Ventures Catalyst programme at the Royal Society of Chemistry.